<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-106511" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Linitis Plastica(Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>El-Nakeep</surname>
            <given-names>Sarah</given-names>
          </name>
          <aff>Gastroentrology and Hepatology Unit, Internal Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kasi</surname>
            <given-names>Anup</given-names>
          </name>
          <aff>University of Kansas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah El-Nakeep declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anup Kasi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>13</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-106511.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Linitis plastica (LP) term was first introduced to the medical field in 1779 by&#x000a0;Lieudaut to describe a scirrhous and rigid type of gastric tissue with a deadly outcome.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref>&#x000a0;Then later described in more detail in 1859 by Dr. William Brinton, who thought it was a benign condition of the stomach with unique abnormalities, including macroscopic thickening of the gastric wall and sub-mucosal hypertrophy consisting mainly of connective and muscular tissues. The microscopic appearance consisted of bands of filaments looking like linen and hence the term &#x0201c;linitis.&#x0201d; As a result, if scarce malignant cells in the tissue, it remained debatable for a long time whether this was a benign or a malignant disorder, which was finally determined in 1953 by Dr. Arthur Stout. He stated that it is a cancerous tissue; characterized by the fibrous scar-like tissue, produced in abundant amounts in this disease.<xref ref-type="bibr" rid="article-106511.r2">[2]</xref></p>
        <p>LP, a phenotype of gastric carcinoma, is interchangeably but not accurately termed Borrmann type 4, which occurs in the Asian population.<xref ref-type="bibr" rid="article-106511.r3">[3]</xref>&#x000a0;Other interchangeable terms include; Schirrous carcinoma, Lauren carcinoma, or signet cell carcinoma.</p>
      </sec>
      <sec id="article-106511.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of&#x000a0;linitis plastica is not fully understood, and a lot of research is done to uncover the exact cause of the disease. Gastric cancer in general and LP as a subcategory are more prevalent in the American and Asian populations, especially in Japan, Korea, and China. This could be related to the type of food, mainly low fiber diet, or the ethnicity of the population.<xref ref-type="bibr" rid="article-106511.r4">[4]</xref><xref ref-type="bibr" rid="article-106511.r5">[5]</xref>&#x000a0;</p>
        <p>On the other hand, LP is not associated with <italic toggle="yes">H.pylori</italic> infection or chronic active gastritis.<xref ref-type="bibr" rid="article-106511.r6">[6]</xref>&#x000a0;Genetic factors play an important role, such as the CDH1 gene and the HER2 gene.</p>
      </sec>
      <sec id="article-106511.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Linitis plastica occurs in 7&#x000a0;to 10% of all primary gastric cancer cases.<xref ref-type="bibr" rid="article-106511.r7">[7]</xref>&#x000a0;Its prevalence among all gastric carcinomas ranges from 3&#x000a0;to 19%.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref>&#x000a0;The prevalence of diffuse tumors is higher in the young age and the females.<xref ref-type="bibr" rid="article-106511.r2">[2]</xref></p>
      </sec>
      <sec id="article-106511.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of&#x000a0;linitis plastica is still unclear, multiple linkages to various genetic mutations have been hypothesized, but as gastric cancer has risk factors like ethnicity, hereditary, diet factors, etc., these are all incriminated as having a possible role in the induction of cancer.</p>
        <p>Secondary LP occurs with various types of cancer as a metastasis from primary cancer, for example, breast cancer, and gastric cancer. Still, in some cases, there are rare reports of the primary lesion arising from the colon or ovarian cancer. Also, metastasis for breast carcinoma recurrence could present as LP. The secondary sites of cancer might be in the colon or other gastrointestinal organs but histologically identifiable. The characteristics of submucosal infiltration along with attenuated rigid lumen, occur more commonly in the rectum and sigmoid colon.<xref ref-type="bibr" rid="article-106511.r8">[8]</xref><xref ref-type="bibr" rid="article-106511.r9">[9]</xref><xref ref-type="bibr" rid="article-106511.r10">[10]</xref><xref ref-type="bibr" rid="article-106511.r11">[11]</xref></p>
        <p>E-cadherin protein was implicated 20 years ago as the cause of the diffuse type of gastric cancer and lobular type of breast cancer. E-cadherin&#x000a0;causes tumor suppression, and a mutation in its germine gene CDH1 will limit that effect. Risk of acquiring cancer increases with heterozygous CDH1.<xref ref-type="bibr" rid="article-106511.r12">[12]</xref>&#x000a0;This hereditary type of LP tends to run in the family members (first and second-degree relatives), especially below the age of 40 years old. Prophylactic aggressive measures in the carriers of this gene&#x000a0;require&#x000a0;total gastrectomy according to expert recommendations.<xref ref-type="bibr" rid="article-106511.r12">[12]</xref></p>
        <p>Other associated genes include Human epidermal growth factor-2 HER2 gene upregulation&#x000a0;or increased expression of its protein.<xref ref-type="bibr" rid="article-106511.r13">[13]</xref></p>
      </sec>
      <sec id="article-106511.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Linitis plastica is not considered a separate entity in the staging or classification of gastric cancer; rather, it is taken as just a part of the diffuse infiltrating gastric cancer, but its influence on morbidity and mortality is well established.<xref ref-type="bibr" rid="article-106511.r14">[14]</xref></p>
        <p>&#x0201c;Leather bottle&#x0201d; was a term describing the gross appearance of the stomach, where there is limited distensibility of the gastric volume.<xref ref-type="bibr" rid="article-106511.r15">[15]</xref></p>
        <p><bold>Macroscopic Appearance:</bold>&#x000a0;Diffuse infiltration of tumorous tissue in the submucosa and muscularis propria layers of the stomach. The gastric wall is markedly rigid and thickened.</p>
        <p><bold>Microscopic Appearance:</bold>&#x000a0;Stromal hypertrophy and hyperplasia with poorly differentiated adenocarcinoma and signet ring cells infiltration hence the term &#x0201c;signet cell carcinoma.&#x0201d;<xref ref-type="bibr" rid="article-106511.r14">[14]</xref><xref ref-type="bibr" rid="article-106511.r3">[3]</xref></p>
      </sec>
      <sec id="article-106511.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Linitis plastica is mostly asymptomatic till advanced disease; this is attributed to the weak sensitivity of the stomach to the limitation of its volume. The symptomatic cases mostly present with dyspepsia (55%) along with vomiting (33%) associated with regurgitation of food from the esophagus and dysphagia (33%) due to the infiltration of the submucosa and muscle layer with gastric wall stromal thickening, thus causing massive limitation in the stomach distensibility.<xref ref-type="bibr" rid="article-106511.r16">[16]</xref></p>
        <p>Symptoms include pain in the stomach, the feeling of a lump in the epigastrium, and unintentional weight loss.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref></p>
      </sec>
      <sec id="article-106511.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>One of the difficult aspects of diagnosing linitis plastica; is the fact that the disease is infiltrating the submucosa and sparing the mucosa; thus, superficial biopsies taken during diagnostic upper gastrointestinal endoscopy may result inconclusive. Recently the role of endoscopic ultrasound proved to be important in the diagnosis of LP cases, as the ultrasound will determine the submucosal thickening and infiltration along with assessing the regional lymph node size/architecture and infiltration of the adjacent structures.<xref ref-type="bibr" rid="article-106511.r17">[17]</xref></p>
        <p>The accuracy of EUS in LP ranges from 64&#x000a0;to 92% in the diagnosis of the T stage and 50&#x000a0;to 90% in the diagnosis of the N stage.<xref ref-type="bibr" rid="article-106511.r18">[18]</xref></p>
        <p>Types of biopsies used are brush cytology and superficial biopsy in the case of regular upper endoscopy and fine-needle biopsy from the EUS. Fine-needle aspiration/biopsy can be performed from enlarged lymph nodes.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref></p>
        <p>High-resolution computed tomography CT scan with contrast is the gold standard for initial diagnosis to detect deep gastric wall thickening in the submucosa and muscle layer, also to detect peritoneal, liver, and lymph node metastasis, thus staging of the disease, and remove any doubt by eliminating other possible differential diagnoses. Also, it could be helpful in early detection of the disease as false-negative biopsies in LP may reach 30% due to unscathed superficial mucosa in the early stages of the disease. Delayed-phase enhancement after injection of the contrast is diagnostic to LP lesion. MRI could be an alternative, equally efficient diagnostic measure if CT is contraindicated or not feasible.<xref ref-type="bibr" rid="article-106511.r19">[19]</xref><xref ref-type="bibr" rid="article-106511.r12">[12]</xref></p>
        <p>Peritoneal lavage by laparoscopy is diagnostic in the case of peritoneal carcinomatosis. CEA and CA19-9 could be elevated and might help with the prognosis, but they lack sensitivity and specificity for LP in serum, although they might be more beneficial in peritoneal lavage in peritoneal metastasis and lymph node invasion, supporting the role of adjuvant chemotherapy in the treatment.<xref ref-type="bibr" rid="article-106511.r20">[20]</xref></p>
      </sec>
      <sec id="article-106511.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>While oncology specialists lean towards the palliative systemic therapy, convinced that most cases are already metastasizing at disease presentation and that surgery is a part of a palliative regimen to only 20% of the patients. However, surgery is still considered the only cure for the disease with absent alternatives, backed by the relatively improved survival.<xref ref-type="bibr" rid="article-106511.r21">[21]</xref></p>
        <p>Gastrectomy with systemic therapy, either radiotherapy or chemotherapy, seems a promising approach in some cases of localized linitis plastica. It is associated with increased overall survival.<xref ref-type="bibr" rid="article-106511.r3">[3]</xref></p>
        <p>Total gastrectomy is considered the only cure for the disease, but this is limited by many factors. Firstly, the eligible patients for total gastrectomy are a minority due to the late stage of the disease at the initial presentation in most cases. Secondly, this is a major operation with a high risk of mortality and morbidity, which may affect survival postoperatively.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref>&#x000a0;Thirdly, the malnutrition status that the patients suffer postoperatively, most commonly in the form of anemia, is also a limiting factor.<xref ref-type="bibr" rid="article-106511.r22">[22]</xref></p>
        <p>The guidelines differ from western and eastern countries. In western countries, the preferable course of action is total gastrectomy with D2 lymph node dissection associated with peri or postoperative adjuvant chemotherapy. However, this is different in eastern countries where the preferable standard course is postoperative adjuvant chemotherapy after total gastrectomy.<xref ref-type="bibr" rid="article-106511.r23">[23]</xref>&#x000a0;S-1 adjuvant oral plus cisplatin chemotherapy is a standard postoperative regimen in Japan.<xref ref-type="bibr" rid="article-106511.r24">[24]</xref>&#x000a0;Personalized medicine is another proposed line of treatment depending on the patient biological markers and staging, where a combination of more than one course of chemotherapy or sequential courses according to the disease progress may yield good results in selected advanced cases.<xref ref-type="bibr" rid="article-106511.r25">[25]</xref></p>
      </sec>
      <sec id="article-106511.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following are some important differentials which should be taken into consideration while making the diagnosis of linitis plastica:</p>
        <list list-type="order">
          <list-item>
            <p>Atrophic gastritis (as this could present with dyspepsia and decreased distensibility along with malnutrition due to destruction of the mucosa and loss of mucosal folds)</p>
          </list-item>
          <list-item>
            <p>Hypertrophic H.pylori chronic gastritis (this may resemble the hypertrophy in mucosal folds that occurs in LP due to submucosal infiltration, but here distensibility will remain intact)</p>
          </list-item>
          <list-item>
            <p>Corrosive gastritis (it will be accompanied by corrosive esophagitis with identification from the history)</p>
          </list-item>
          <list-item>
            <p>Other types of diffuse infiltration as lymphoma, GIST, non-Hodgkins lymphoma, adenocarcinoma, Bormann type 3 and 4 (histopathological differentiation will resolve the issue)</p>
          </list-item>
          <list-item>
            <p>Watermelon stomach with portal hypertension and loss of distensibility from the congestion (accompanied by liver decompensation and signs of portal hypertension)</p>
          </list-item>
          <list-item>
            <p>Post partial gastrectomy loss of gastric volume and distensibility (history of the previous operation is identified)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-106511.s10" sec-type="Surgical Oncology">
        <title>Surgical Oncology</title>
        <p>Median survival after surgical resection is about 16.7 months in comparison to 3.6 months in the case of medical-management only. These are similar survival rates when compared to non-LP adenocarcinoma patients.<xref ref-type="bibr" rid="article-106511.r26">[26]</xref></p>
        <p>During surgical resection; the clear margins and frozen section examination intraoperatively (to determine negative margins) ensure cure and decrease disease recurrence.<xref ref-type="bibr" rid="article-106511.r21">[21]</xref></p>
      </sec>
      <sec id="article-106511.s11" sec-type="Radiation Oncology">
        <title>Radiation Oncology</title>
        <p>Radiation, along with chemotherapy, may be used&#x000a0;as an alternative neoadjuvant therapy prior to surgery instead of chemotherapy alone. If gastrectomy is performed upfront, and especially in the setting of positive margins, radiation therapy, along with chemotherapy, could be considered postoperatively.</p>
      </sec>
      <sec id="article-106511.s12" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>A randomized clinical trial phase 3 on patients with linitis plastica on biological therapy for diffuse gastric cancer type 4 or large type 3 tumors showed that adjuvant chemotherapy S-1 (standard in Japan) with gastrectomy is no different than neoadjuvant chemotherapy and standard postoperative chemotherapy.<xref ref-type="bibr" rid="article-106511.r25">[25]</xref></p>
      </sec>
      <sec id="article-106511.s13" sec-type="Medical Oncology">
        <title>Medical Oncology</title>
        <p>Metastasis is one of the most important determinants of survival. The disease tends to locally disseminate in the peritoneum, causing peritoneal carcinomatosis, which indicates rapid disease progression. Lymph node metastasis, rectal and colon metastases, and bone metastasis are common in advanced disease and associated with poor prognosis and failure to surgical cure.<xref ref-type="bibr" rid="article-106511.r1">[1]</xref></p>
      </sec>
      <sec id="article-106511.s14" sec-type="Staging">
        <title>Staging</title>
        <p>There is a limited clinical significance of diagnosis linitis plastica as a separate entity and difficulty in including it to the known classification systems, which encouraged some authors to abandon the term altogether. This is helped by the lack of consensus agreement on LP definition due to overlapping with other types of cancers that contain signet ring cells. This is not universally agreed, as others still think that this is a well determinant disease with known risk stratification that yields a benefit to the management of patients by predicting the prognosis of the cases.<xref ref-type="bibr" rid="article-106511.r2">[2]</xref><xref ref-type="bibr" rid="article-106511.r27">[27]</xref></p>
        <p>Although there are numerous classification systems for gastric cancer, there is still no gold standard. Here is an overview of the most used classifications:</p>
        <list list-type="bullet">
          <list-item>
            <p>WHO classification: it mainly depends on describing the microscopic appearance of cancer (which is considered its main limiting property) to the following; papillary, tubular, mucinous, mixed adenocarcinomas, and poorly cohesive (which contains the characteristic signet ring cells).<xref ref-type="bibr" rid="article-106511.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Cancer stromal volume classification: this classification depends on the abundancy of stromal tissue and has medullary, intermediate, and scirrhous types, the last being the most abundant. It is a part of the Japanese classification that shares some of the characteristics of the Bormann type 3 and 4.<xref ref-type="bibr" rid="article-106511.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p>Bormann classification: it is used mainly in Eastern Asian countries. In this classification, LP is similar to Bormann type 4 with its diffuse infiltrating characteristic and thickened gastric mucosa. It is most common in females and young age; the difference is mainly on the prevalence of infiltration in LP is more in the submucosa, which may cause hypertrophy and folding of the mucosa. It is positioned mainly in the upper gastric body with more than one-third infiltration of the stomach, while in Bormann type 4 it is equally distributed in the mucosa and submucosa and positioned in the antrum.<xref ref-type="bibr" rid="article-106511.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Lauren classification: it is classified according to microscopic appearance and origin into; diffuse (which carries similarity to LP and Bormann type 4), intestinal (with glandular like structure), or mixed and indeterminate types.<xref ref-type="bibr" rid="article-106511.r2">[2]</xref></p>
          </list-item>
        </list>
        <p>As any cancerous tumor, TNM classification applies to know the extent of infiltration locally and systemically, according to AJCC Cancer staging.<xref ref-type="bibr" rid="article-106511.r31">[31]</xref></p>
      </sec>
      <sec id="article-106511.s15" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Linitis plastica carries a poor prognosis owing to the late stage of metastatic disease at the time of the initial discovery of the disease. This late diagnosis is due to absent clinical manifestations at the early stages of the disease, as the gastric mucosa is mostly spared, rendering the patient asymptomatic until the late stages.<xref ref-type="bibr" rid="article-106511.r15">[15]</xref><xref ref-type="bibr" rid="article-106511.r12">[12]</xref></p>
        <p>Median survival ranges from 5&#x000a0;to 17 months in case of surgical intervention.<xref ref-type="bibr" rid="article-106511.r3">[3]</xref>&#x000a0;Five-year survival is very low, ranging from 3&#x000a0;to 10% <xref ref-type="bibr" rid="article-106511.r32">[32]</xref></p>
      </sec>
      <sec id="article-106511.s16" sec-type="Complications">
        <title>Complications</title>
        <p>Complications are related to the "leathery bottle stomach, which causes limitation in digestion and absorption of food; this will lead to malnutrition and severe cachexia of the patients. As the disease advances, a surgical bypass may be mandatory to relieve the lack of motility in the rigid wall and obstruction. Metastasis could affect various organs as liver metastasis, peritoneal metastasis, causing ascites, liver cell failure, or biliary obstruction.</p>
      </sec>
      <sec id="article-106511.s17" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education in linitis plastica is very helpful, as most of the cases are diagnosed in the advanced or non-curative stage. The patient's understanding of his condition is crucial, and the various options available for his management should be explained clearly. The option of personalized medicine in advanced cases needs an informed and educated patient, also the nutrition of the patient, either oral or parental with or without the need for surgery, should be discussed to ensure the best outcome. Genetic testing and counseling of the patient's relatives and the potential need for prophylactic surgery needs an informed and understanding patient to discuss the condition with his own family.</p>
      </sec>
      <sec id="article-106511.s18" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Linitis plastica needs the coordination of an interprofessional team of gastroenterologists, oncologists, gastric surgeons, radiologists, pathologists, nutritionists, and endstage nursing care. This team should plan the best strategy for each patient on a one-to-one basis because this disease is uncommon with poor prognosis. Communication with the patient and caregivers is mandatory to help in deciding what is best for the patient.<xref ref-type="bibr" rid="article-106511.r33">[33]</xref></p>
        <p>A good diagnosis starts with the radiologist and gastroenterologist, deciding to refer or formulate a team according to the case. The team will decide the best plan that suits the individual patient. Surgical gastrectomy, either partial or total with a suitable margin, is decided by the surgeon in coordination with the oncologist. Postoperative management by a nutritionist and gastroenterologist to relieve the symptoms and improve the quality of life is advisable.&#x000a0;The oncologist decides the best radioactive or chemotherapeutic plan postoperative or as a palliative measure from the beginning to the advanced stages. Nursing care and social workers help the patients in different stages of the disease, especially in the late stages.</p>
        <p>The level of evidence for LP management is mainly derived from cohort and case series studies due to the rarity of cases and the individuality of the disease.<xref ref-type="bibr" rid="article-106511.r16">[16]</xref> [Level&#x000a0;3]</p>
      </sec>
      <sec id="article-106511.s19">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=106511&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=106511">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/linitis-plastica/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=106511">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/106511/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=106511">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-106511.s20">
        <title>References</title>
        <ref id="article-106511.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastoraki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Papanikolaou</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Sakorafas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Safioleas</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Facing the challenge of managing linitis plastica--review of the literature.</article-title>
            <source>Hepatogastroenterology</source>
            <year>2009</year>
            <season>Nov-Dec</season>
            <volume>56</volume>
            <issue>96</issue>
            <fpage>1773</fpage>
            <page-range>1773-8</page-range>
            <pub-id pub-id-type="pmid">20214236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agnes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Estrella</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Badgwell</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The significance of a nineteenth century definition in the era of genomics: linitis plastica.</article-title>
            <source>World J Surg Oncol</source>
            <year>2017</year>
            <month>Jul</month>
            <day>05</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>123</fpage>
            <pub-id pub-id-type="pmid">28679451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ikoma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Agnes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Minsky</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Estrella</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mansfield</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ajani</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Badgwell</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Linitis Plastica: a Distinct Type of Gastric Cancer.</article-title>
            <source>J Gastrointest Surg</source>
            <year>2020</year>
            <month>May</month>
            <volume>24</volume>
            <issue>5</issue>
            <fpage>1018</fpage>
            <page-range>1018-1025</page-range>
            <pub-id pub-id-type="pmid">31754987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zali</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rezaei-Tavirani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Azodi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gastric cancer: prevention, risk factors and treatment.</article-title>
            <source>Gastroenterol Hepatol Bed Bench</source>
            <year>2011</year>
            <season>Fall</season>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>175</fpage>
            <page-range>175-85</page-range>
            <pub-id pub-id-type="pmid">24834180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M A</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Agudo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bueno-de-Mesquita</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Palli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boeing</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berrino</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sacerdote</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tumino</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berglund</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Manjer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johansson</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Stenling</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dorronsoro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Barricarte</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tormo</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Quiros</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Key</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Bingham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Linseisen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaaks</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Overvad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tj&#x000f8;nneland</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peeters</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Numans</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ock&#x000e9;</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Clavel-Chapelon</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Boutron-Ruault</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Trichopoulou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Slimani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jenab</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riboli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Cereal fiber intake may reduce risk of gastric adenocarcinomas: the EPIC-EURGAST study.</article-title>
            <source>Int J Cancer</source>
            <year>2007</year>
            <month>Oct</month>
            <day>01</day>
            <volume>121</volume>
            <issue>7</issue>
            <fpage>1618</fpage>
            <page-range>1618-23</page-range>
            <pub-id pub-id-type="pmid">17582605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vilaichone</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Panarat</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Aekpongpaisit</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mahachai</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Clinical characteristics and Helicobacter pylori status of gastric cancer in Thailand.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2014</year>
            <volume>15</volume>
            <issue>20</issue>
            <fpage>9005</fpage>
            <page-range>9005-8</page-range>
            <pub-id pub-id-type="pmid">25374243</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Hyung</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Noh</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients.</article-title>
            <source>J Surg Oncol</source>
            <year>2009</year>
            <month>Jun</month>
            <day>01</day>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>395</fpage>
            <page-range>395-401</page-range>
            <pub-id pub-id-type="pmid">19347884</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Viso Vidal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Villanueva Pav&#x000f3;n</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jorquera Plaza</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma.</article-title>
            <source>Rev Esp Enferm Dig</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>111</volume>
            <issue>4</issue>
            <fpage>326</fpage>
            <page-range>326-328</page-range>
            <pub-id pub-id-type="pmid">30859840</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lior</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chin Ng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>A rare case of linitis plastica of the colon from ovarian carcinoma.</article-title>
            <source>J Surg Case Rep</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>2019</volume>
            <issue>3</issue>
            <fpage>rjz089</fpage>
            <pub-id pub-id-type="pmid">30949339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feinberg</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Feinberg</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Primary linitis plastica of the entire colon in a background of ulcerative colitis: a case report.</article-title>
            <source>World J Surg Oncol</source>
            <year>2015</year>
            <month>Feb</month>
            <day>04</day>
            <volume>13</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">25649787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Go</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mehta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bihun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Carpenter</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ghani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Metastatic Breast Cancer Presenting as a Gastric Primary with Linitis Plastica: a Case Report and Review of Literature.</article-title>
            <source>J Gastrointest Cancer</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>698</fpage>
            <page-range>698-702</page-range>
            <pub-id pub-id-type="pmid">32034640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Post</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Vogelaar</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guilford</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Huntsman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hoogerbrugge</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Caldas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schreiber</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Hardwick</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Ausems</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Bardram</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Benusiglio</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Bisseling</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Bleiker</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boussioutas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cats</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Coit</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>DeGregorio</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Figueiredo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ford</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Heijkoop</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hermens</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Humar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kaurah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ligtenberg</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>O'Donovan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pinheiro</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ragunath</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rasenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roviello</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schackert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Seruca</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ter Huurne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tischkowitz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joe</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>van Dijck</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>van Grieken</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>van Hillegersberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Sandick</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Vehof</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Krieken</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.</article-title>
            <source>J Med Genet</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>6</issue>
            <fpage>361</fpage>
            <page-range>361-74</page-range>
            <pub-id pub-id-type="pmid">25979631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uprak</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Attaallah</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>&#x000c7;elikel</surname>
                <given-names>&#x000c7;A</given-names>
              </name>
              <name>
                <surname>Ayranc&#x00131;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ye&#x0011f;en</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>HER-2 incidence in gastric cancer, its association with prognosis and clinicopathological parameters.</article-title>
            <source>Ulus Cerrahi Derg</source>
            <year>2015</year>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>207</fpage>
            <page-range>207-13</page-range>
            <pub-id pub-id-type="pmid">26668528</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thapa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Coppola</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Almhanna</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pimiento</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Marquez</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Hodul</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Does histology really influence gastric cancer prognosis?</article-title>
            <source>J Gastrointest Oncol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>1026</fpage>
            <page-range>1026-1036</page-range>
            <pub-id pub-id-type="pmid">29299363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kajihara</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Linitis plastica: 'leather bottle' stomach.</article-title>
            <source>QJM</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>112</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-234</page-range>
            <pub-id pub-id-type="pmid">30295839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jafferbhoy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shiwani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rustum</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Managing Gastric Linitis Plastica: Keep the scalpel sheathed.</article-title>
            <source>Sultan Qaboos Univ Med J</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>451</fpage>
            <page-range>451-3</page-range>
            <pub-id pub-id-type="pmid">23984032</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khara</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Confer</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Diehl</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Johal</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>The role of EUS in missed and known linitis plastica.</article-title>
            <source>Endosc Ultrasound</source>
            <year>2020</year>
            <season>May-Jun</season>
            <volume>9</volume>
            <issue>3</issue>
            <fpage>202</fpage>
            <page-range>202-204</page-range>
            <pub-id pub-id-type="pmid">32584317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shan</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>GQ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>YM</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic ultrasonographic features of gastric linitis plastica in fifty-five Chinese patients.</article-title>
            <source>J Zhejiang Univ Sci B</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>844</fpage>
            <page-range>844-8</page-range>
            <pub-id pub-id-type="pmid">24009205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burgain</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Germain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bastien</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Orry</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Chon&#x000e9;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Claudon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Computed tomography features of gastrointestinal linitis plastica: spectrum of findings in early and delayed phase imaging.</article-title>
            <source>Abdom Radiol (NY)</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>1370</fpage>
            <page-range>1370-7</page-range>
            <pub-id pub-id-type="pmid">26814502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tokuda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Natsugoe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakajo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miyazono</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ishigami</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hokita</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Takao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eizuru</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aikou</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer.</article-title>
            <source>Int J Mol Med</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>79</fpage>
            <page-range>79-84</page-range>
            <pub-id pub-id-type="pmid">12469223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blackham</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Swords</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Fino</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Squires</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Poultsides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Bloomston</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Pawlik</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Spolverato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Worhunsky</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Maithel</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Votanopoulos</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>1203</fpage>
            <page-range>1203-11</page-range>
            <pub-id pub-id-type="pmid">26530447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cidon</surname>
                <given-names>EU</given-names>
              </name>
            </person-group>
            <article-title>Nutritional Status After Total Gastrectomy for Gastric Cancer.</article-title>
            <source>World J Oncol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>87</fpage>
            <page-range>87-90</page-range>
            <pub-id pub-id-type="pmid">29147185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tokunaga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Aburatani</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Matsuyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kinugasa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives.</article-title>
            <source>Surg Today</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>30</fpage>
            <page-range>30-37</page-range>
            <pub-id pub-id-type="pmid">31612329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Terashima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iwasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mizusawa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Katayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Katai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yoshikawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kaji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hirao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kurita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takagi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boku</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sasako</surname>
                <given-names>M</given-names>
              </name>
              <collab>Stomach Cancer Study Group, Japan Clinical Oncology Group</collab>
            </person-group>
            <article-title>Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).</article-title>
            <source>Gastric Cancer</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>1044</fpage>
            <page-range>1044-1052</page-range>
            <pub-id pub-id-type="pmid">30827001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahjoubi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cecchi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Massard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Calabro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Gazzah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bahleda</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jamme</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goere</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lacroix</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Adam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Heukamp</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Trenta</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hembrough</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Soria</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Sternberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ducreux</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.</article-title>
            <source>Tumori</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>104</volume>
            <issue>6</issue>
            <fpage>NP38</fpage>
            <page-range>NP38-NP41</page-range>
            <pub-id pub-id-type="pmid">29714649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Ranaghan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clements</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Survival following operative management of gastric linitis plastica compared with non-operative management.</article-title>
            <source>Ann R Coll Surg Engl</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>99</volume>
            <issue>3</issue>
            <fpage>228</fpage>
            <page-range>228-232</page-range>
            <pub-id pub-id-type="pmid">27809576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vivier-Chicoteau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Coriat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonnot</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Goere</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Roche</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dior</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goujon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Morgant</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pocard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Glehen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Aparicio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Gornet</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Development and internal validation of a diagnostic score for gastric linitis plastica.</article-title>
            <source>Gastric Cancer</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>639</fpage>
            <page-range>639-647</page-range>
            <pub-id pub-id-type="pmid">32103376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagtegaal</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Odze</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Klimstra</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paradis</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rugge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schirmacher</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Washington</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cree</surname>
                <given-names>IA</given-names>
              </name>
              <collab>WHO Classification of Tumours Editorial Board</collab>
            </person-group>
            <article-title>The 2019 WHO classification of tumours of the digestive system.</article-title>
            <source>Histopathology</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>76</volume>
            <issue>2</issue>
            <fpage>182</fpage>
            <page-range>182-188</page-range>
            <pub-id pub-id-type="pmid">31433515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <collab>Japanese Gastric Cancer Association</collab>
            <article-title>Japanese classification of gastric carcinoma: 3rd English edition.</article-title>
            <source>Gastric Cancer</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-12</page-range>
            <pub-id pub-id-type="pmid">21573743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Borrmann Type 4 Advanced Gastric Cancer: Focus on the Development of Scirrhous Gastric Cancer.</article-title>
            <source>Clin Endosc</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>336</fpage>
            <page-range>336-45</page-range>
            <pub-id pub-id-type="pmid">27456608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amin</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Edge</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Gershenwald</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Brookland</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gress</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Byrd</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Winchester</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.</article-title>
            <source>CA Cancer J Clin</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>93</fpage>
            <page-range>93-99</page-range>
            <pub-id pub-id-type="pmid">28094848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schauer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peiper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Theisen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knoefel</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in patients with diffuse type gastric cancer (linitis plastica) after operative treatment.</article-title>
            <source>Eur J Med Res</source>
            <year>2011</year>
            <month>Jan</month>
            <day>27</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-33</page-range>
            <pub-id pub-id-type="pmid">21345767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-106511.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boniface</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Schefter</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Meguid</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Wingrove</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>McCarter</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary management for esophageal and gastric cancer.</article-title>
            <source>Cancer Manag Res</source>
            <year>2016</year>
            <volume>8</volume>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">27217796</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
